Literature DB >> 15345112

High-risk premenopausal women's experiences of undergoing prophylactic oophorectomy: a descriptive study.

Nina Hallowell1, James Mackay, Martin Richards, Martin Gore, Ian Jacobs.   

Abstract

Women who are at increased risk of developing ovarian cancer because of their family history may need to make decisions about the medical management of their cancer risk--whether to have ovarian screening or undergo prophylactic surgery. This qualitative study explores the perceived physical and emotional implications of undergoing preventative surgery using data collected during interviews with 23 high-risk premenopausal women who had undergone prophylactic oophorectomy because of their family history of cancer. Despite the fact that all of these women regarded their decision to undergo surgery extremely positively, 20 women also described what they regarded as the costs of undergoing surgery. These included post-operative complications, the onset of menopausal symptoms, side effects of hormone replacement therapy, and negative effects on body image and gender identity. The perceived benefits of surgery were described as risk reduction, enabling one to fulfil family obligations, removing the need for gynecological screening, cessation of menstruation, and positive side effects of hormone replacement therapy. This study suggests there is a need to inform women about potential physical and emotional sequelae of oophorectomy prior to undergoing this procedure.

Entities:  

Mesh:

Year:  2004        PMID: 15345112     DOI: 10.1089/gte.2004.8.148

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  12 in total

1.  Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation.

Authors:  Dongwon Kim; Eunyoung Kang; Euijun Hwang; Young Sun; Yoonsun Hwang; Cha Kyong Yom; Kidong Kim; Jae Hong No; Yong-Beom Kim; Sung-Won Kim
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

2.  The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.

Authors:  Ramona Moldovan; Sianan Keating; Tara Clancy
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

3.  Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery.

Authors:  Nina Hallowell; Brandi Baylock; Louise Heiniger; Phyllis N Butow; Deepa Patel; Bettina Meiser; Christobel Saunders; Melanie A Price
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

4.  Confocal microlaparoscope for imaging the fallopian tube.

Authors:  Tzu-Yu Wu; Andrew R Rouse; Setsuko K Chambers; Kenneth D Hatch; Arthur F Gmitro
Journal:  J Biomed Opt       Date:  2014-11       Impact factor: 3.170

Review 5.  New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy.

Authors:  Suzanne M Miller; Pagona Roussi; Mary B Daly; John Scarpato
Journal:  Clin Cancer Res       Date:  2010-09-09       Impact factor: 12.531

6.  A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.

Authors:  Carolyn Y Fang; Carol Cherry; Karthik Devarajan; Tianyu Li; John Malick; Mary B Daly
Journal:  Gynecol Oncol       Date:  2009-01-13       Impact factor: 5.482

7.  The FAP self-concept scale (adult form).

Authors:  Mary Jane Esplen; Noreen Stuckless; Terri Berk; Kate Butler; Steve Gallinger
Journal:  Fam Cancer       Date:  2008-08-13       Impact factor: 2.375

Review 8.  Genetics: breast cancer as an exemplar.

Authors:  Rebekah Hamilton
Journal:  Nurs Clin North Am       Date:  2009-09       Impact factor: 1.208

9.  Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer.

Authors:  Rebekah Hamilton; Janet K Williams; Barbara J Bowers; Kathleen Calzone
Journal:  J Genet Couns       Date:  2008-11-01       Impact factor: 2.537

10.  Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk.

Authors:  Claire E Wakefield; Bettina Meiser; Judi Homewood; Michelle Peate; Judy Kirk; Beverley Warner; Elizabeth Lobb; Clara Gaff; Kathy Tucker
Journal:  J Genet Couns       Date:  2007-02-23       Impact factor: 2.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.